SEARCH

SEARCH BY CITATION

References

  • Bocchia, M., Korontsvit, T., Yu, Q., Mackinnon, S., Yang, S.Y., Sette, A. & Scheinberg, D.A. (1996) Specific human cellular immunity to bcr-abl oncogene-derived peptides. Blood, 87, 35873592.
  • Collins, Jr, R.H., Goldstein, S., Giralt, S., Levine, J., Porter, D., Drobyski, W., Barrett, J., Johnson, M., Kirk, A., Horowitz, M. & Parker, P. (2000) Donor leukocyte infusions in acute lymphocytic leukemia. Bone Marrow Transplantation, 26, 511516.
  • Dazzi, F. & Goldman, J. (1999) Donor lymphocyte infusions (Review). Current Opinion in Hematology, 6, 394399.
  • De Bueger, M., Bakker, A., Van Rood, J.-J., Van Der Woude, F. & Goulmy, E. (1992) Tissue distribution of human minor histocompatibility antigens. Ubiquitous versus restricted tissue distribution indicates heterogeneity among human cytotoxic T lymphocyte-defined non-MHC antigens. Journal of Immunology, 149, 17881794.
  • Den Haan, J.J.M., Sherman, N.E., Blokland, E., Huczko, E., Koning, F., Drijfhout, J.W., Skipper, J., Shabanowitz, J., Hunt, D.F., Engelhard, V.H. & Goulmy, E. (1995) Identification of a graft versus host disease-associated human minor histocompatibility antigen. Science, 268, 14761480.
  • Den Haan, J.J.M., Meadows, L.M., Wang, W., Pool, J., Blokland, E., Bishop, T.L., Reinhardus, C., Shabanowitz, J., Offringa, R., Hunt, D.F., Engelhard, V.H. & Goulmy, E. (1998) The human immunodominant minor histocompatibility antigen HA-1 represents a diallelic gene with a single amino acid polymorphism. Science, 279, 10541057.
  • Eibl, B., Schwaighofer, H., Nachbaur, D., Marth, C., Gächter, A., Knapp, R., Böck, G., Gassner, C., Schiller, L., Petersen, F. & Niederwieser, D. (1996) Evidence for a graft-versus-tumor effect in a patient treated with marrow ablative chemotherapy and allogeneic bone marrow transplantation for breast cancer. Blood, 88, 15011508.
  • Eibl, B., Ebner, S., Duba, C., Böck, G., Romani, N., Erdel, M., Gächter, A., Niederwieser, D. & Schuler, G. (1997) Dendritic cells generated from blood precursors of chronic myelogenous leukemia patients carry the Philadelphia translocation and can induce a CML-specific primary cytotoxic T-cell response. Genes, Chromosomes and Cancer, 20, 215223.
  • Faber, L.M., Van Der Houven, J., Goulmy, E., Hooftman-den Otter, A.L., Van Luxemburg-Heijs, S.A.P., Willemze, R. & Falkenburg, J.H. (1995) Recognition of clonogenic leukemic cells, remission bone marrow and HLA-identical bone marrow by CD8+ or CD4+ minor histocompatibility antigen-specific cytotoxic T lymphocytes. Journal of Clinical Investigation, 96, 877883.
  • Falkenburg, F.J.H., Goselink, H.M., Van Der Harst, D., Van Luxemburg-Heijs, S.A.P., Kooy-Winkelaar, Y.M.C., Faber, L.M., De Kroon, J., Brand, A., Fibbe, W.E., Willemze, R. & Goulmy, E. (1991) Growth inhibition of clonogenic leukemic precursor cells by minor histocompatibility antigen specific cytotoxic T lymphocytes. Journal of Experimental Medicine, 174, 2733.
  • Falkenburg, F.J.H., Smit, W.M. & Willemze, R. (1997) Cytotoxic T-lymphocyte (CTL) responses against acute or chronic myeloid leukemia. Immunological Reviews, 157, 223230.
  • Ferrara, J.-L. (2000) Pathogenesis of acute graft-versus-host disease: cytokines and cellular effectors. Journal of Hematotherapy and Stem Cell Research, 9, 299306.
  • Gallardo, D., Arostegui, J.I., Balas, A., Torres, A., Caballero, D., Carreras, E., Brunet, S., Jimenez, A., Mataix, R., Serrano, D., Vallejo, C., Sanz, G., Solano, C., Rodriguez-Luaces, M., Marin, J., Baro, J., Sanz, C., Roman, J., Gonzales, M., Martorell, J., Sierra, J., Martin, C., De La Camara, R. & Granena, A. (GvHD Subcommittee of the Grupo Espanol de Trasplante Hemapoyetico) (2001) Disparity for the minor histocompatibility antigen HA-1 is associated with an increased risk of acute graft-versus-host disease (GvHD) but it does not affect chronic GvHD incidence, disease-free survival or overall survival after allogeneic human leucocyte antigen-identical sibling donor transplantation. British Journal of Haematology, 114, 931936.DOI: 10.1046/j.1365-2141.2001.03013.x
  • Goulmy, E. (1988) Minor histocompatibility antigens in man and their role in transplantation. Transplantation Reviews, 2, 2953.
  • Goulmy, E. (1997) Human minor histocompatibility antigens: new concepts for marrow transplantation and adoptive immunotherapy. Immunological Reviews, 157, 125140.
  • Goulmy, E., Schipper, R., Pool, J., Blokland, E., Falkenburg, F., Vossen, J., Gratwohl, A., Vogelsang, G.B., Van Houwelingen, H.C. & Van Rood, J.J. (1996) Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation. New England Journal of Medicine, 334, 281285.DOI: 10.1056/NEJM199602013340501
  • Marijt, W.A., Veenhof, W.F., Goulmy, E., Willemze, R., Van Rood, J.J. & Falkenburg, J.H. (1993) Minor histocompatibility antigens HA-1, -2-, and -4-, and HY-specific cytotoxic T-cell clones inhibit human hematopoietic progenitor cell growth by a mechanism that is dependent on direct cell-cell contact. Blood, 82, 37783785.
  • Marijt, W.A.F., Kester, M.G.D.M., Goulmy, E., Mutis, T., Drijfhout, J.W., Willemze, R. & Falkenburg, J.H.F. (2001) Induction of hematopoiesis-specific minor histocompatibility antigen (mHag) HA-1 and HA-2 specific CD8+ T-cells after donor lymphocyte infusion (DLI) for relapsed CML associated with complete molecular remission. Bone Marrow Transplantation, 27, S23 (Abstract).
  • Molldrem, J.J., Lee, P.P., Wang, C., Felio, K., Kantarjian, H.M., Champlin, R.E. & Davis, M.M. (2000) Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemia. Nature Medicine, 6, 10181023.DOI: 10.1038/79526
  • Montillo, M., Tedeschi, A., Centurioni, R. & Leoni, P. (1997) Treatment of relapsed adult acute lymphoblastic leukemia with fludarabine and cytosine arabinoside followed by granulocyte colony-stimulating factor (FLAG-GCSF). Leukemia and Lymphoma, 25, 579583.
  • Mutis, T., Verdijk, R., Schrama, E., Esendam, B., Brand, A. & Goulmy, E. (1999) Feasibility of immunotherapy of relapsed leukemia with ex vivo-generated cytotoxic T lymphocytes specific for hematopoietic system-restricted minor histocompatibility antigens. Blood, 93, 23362341.
  • Rammensee, H.-G., Bachmann, J., Emmerich, N., Bachor, O.-A. & Stevanovic, S. (1999) SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics, 50, 213219.
  • Rufer, N., Wolpert, E., Helg, C., Tiercy, J.M., Gratwohl, A., Chapuis, B., Jeannet, M., Goulmy, E. & Roosnek, E. (1998) HA-1 and the SMCY-derived peptide FIDSYICQV (H-Y) are immunodominant minor histocompatibility antigens after bone marrow transplantation. Transplantation, 66, 910916.
  • Salter, R.-D., Howell, D.-N. & Cresswell, P. (1985) Genes regulating HLA class I antigen expression in T-B lymphoblast hybrids. Immunogenetics, 21, 235246.
  • Tseng, L.-H., Lin, M.-T., Hansen, J.-A., Gooley, T., Pei, J., Smith, A.G., Martin, E.G., Petersdorf, E.W. & Martin, P.J. (1999) Correlation between disparity for the minor histocompatibility antigen HA-1 and the development of acute graft-versus-host disease after allogeneic marrow transplantation. Blood, 94, 29112914.
  • Van der Harst, D., Goulmy, E., Falkenburg, J.H.F., Kooij-Winkelaar, Y.M.C., Luxemburg-Heijs, S.A.P., Goselink, J.M. & Brand, A. (1994) Recognition of minor histocompatibility antigens on lymphocytic and myeloid leukemic cells by cytotoxic T-cell clones. Blood, 83, 10601066.
  • Van Els, C.A.C.M., Bakker, A., Zwinderman, A.H., Zwaan, F.E., Van Rood, J.J. & Goulmy, E. (1990) Effector mechanisms in graft-versus-host disease in response to minor histocompatibility antigens. I. Absence of correlation with cytotoxic effector cells. Transplantation, 50, 6266.
  • Van Els, C.A.C.M., D'Amaro, J., Pool, J., Blokland, E., Bakker, A., Van Elsen, P.J., Van Rood, J. & Goulmy, E. (1992) Immunogenetics of human minor histocompatibility antigens: their polymorphism and immunodominance. Immunogenetics, 35, 161165.
  • Van Lochem, E., Van Der Keur, M., Mommaas, M.A., De Gast, G.C. & Goulmy, E. (1996) Functional expression of minor histocompatibility antigens on human peripheral blood dendritic cells and epidermal Langerhans cells. Transplant Immunology, 4, 151157.DOI: 10.1016/S0966-3274(96)80009-8
  • Warren, E.H., Gavin, M., Greenberg, P.D. & Riddell, S.R. (1998) Minor histocompatibility antigens as targets for T-cell therapy after bone marrow transplantation. Current Opinion in Hematology, 5, 429433.
  • Wilke, M., Pool, J., Den Haan, J.M.M. & Goulmy, E. (1998) Genomic identification of the minor histocompatibility antigen HA-1 locus by allele-specific PCR. Tissue Antigens, 52, 312317.
  • Zier, K., Huber, C. & Braunsteiner, H. (1977) Linear density gradient separation of human lymphocyte subsets. I. Analysis by mixed lymphocyte culture and cell mediated lympholysis responses. European Journal of Immunology, 7, 366370.